Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy.
about
Hepatitis C virus (HCV) infection in Africa: a reviewRibavirin in cancer immunotherapies: controlling nitric oxide augments cytotoxic lymphocyte functionLaboratory Assays for Diagnosis and Management of Hepatitis C Virus InfectionReplicative Homeostasis III: implications for antiviral therapy and mechanisms of response and non-responseHepatitis C virus RNA: Dinucleotide frequencies and cleavage by RNase LCurrent therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C.Review article: predicting response in hepatitis C virus therapy.Viral kinetics in the treatment of chronic hepatitis C.Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+ T-cell immunity.An overview about hepatitis C: a devastating virus.A single nucleotide polymorphism, rs129679860, in the IL28B locus is associated with the viral kinetics and a sustained virological response in a chronic, monoinfected hepatitis C virus genotype-1 Brazilian population treated with pegylated interferEarly hepatitis C virus changes and sustained response in patients with chronic hepatitis C treated with peginterferon alpha-2b and ribavirin.Prediction of treatment outcome in chronic hepatitis C patients based on early viral dynamics during high-dose induction interferon and ribavirin therapy.Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C.Impact of high-dose interferon induction and ribavirin therapy in patients with chronic hepatitis C relapsing after or not responding to interferon monotherapy.Hepatitis C virus genotypes and hepatic fibrosis regulate 24-h decline of serum hepatitis C virus RNA during interferon therapy in patients with chronic hepatitis C.Peptide inhibitors of hepatitis C virus NS3 protease.
P2860
Q26824322-C3E1B241-F25D-49F4-BBAE-5D28ED3A557FQ27473359-2130D1EF-BA68-4C15-81DA-F214FC6E85DAQ27473492-CC5DF4AC-2A74-4A3C-9D78-25E2B7911FDCQ27478215-CCD71BA0-CBD4-4A57-BC43-C929C46EBADAQ27485064-1AB76830-3F74-43F5-96C5-B5F35E1F0EBBQ35588125-896852CB-FCDC-4A9B-AD76-032CB252648EQ36447562-5A0AC054-B4CD-4E5B-ABC4-2F1DE0626007Q36562168-EE6512A8-AE96-4E3A-B3BC-07DD8AE0B7F1Q37194029-118FB704-AFFE-48F5-9318-C6E17D1F7A85Q37719516-EB74A548-624F-434A-94AE-C8A3C5A88CD2Q42986101-AA4A58A0-B7FF-4D38-9055-F61786DF43F9Q42990511-640786FD-1412-4019-99D2-6780AE41C016Q42992776-89FA642F-4866-4748-B39E-2229D3246A6DQ43040757-E0B78512-1567-43E8-9D04-234B11F532CBQ43047387-4594A679-0CF2-439F-AE5E-F1980AE75631Q43049155-FBC88A78-4624-4297-8135-5CD6AB242137Q44705788-D4E7558F-A473-4F09-9931-3917FCD4F763
P2860
Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Predicting response to initial ...... CV RNA results during therapy.
@en
Predicting response to initial ...... CV RNA results during therapy.
@nl
type
label
Predicting response to initial ...... CV RNA results during therapy.
@en
Predicting response to initial ...... CV RNA results during therapy.
@nl
prefLabel
Predicting response to initial ...... CV RNA results during therapy.
@en
Predicting response to initial ...... CV RNA results during therapy.
@nl
P2093
P2860
P1476
Predicting response to initial ...... HCV RNA results during therapy
@en
P2093
J G McHutchison
J J Garaud
J K Albrecht
S C Gordon
T R Morgan
P2860
P304
P356
10.1046/J.1365-2893.2001.00312.X
P50
P577
2001-11-01T00:00:00Z